Comparison CytoMed Therapeutics (GDTC) with Competitors
CytoMed Therapeutics (GDTC) industry is Biotechnology.
Operating Margin
GDTC-535.00%
Industry-2055.25%
Upside+1520.25%
Debt-to-Equity
GDTC7.37%
Industry28.27%
Upside-73.92%
Free Cash Flow Yield
GDTC-43.37%
Industry-1.75%
Upside-41.63%
P/E
GDTC-3.02
Industry-20.52
Upside+1749.23%
P/S
GDTC14.02
Industry10.01
Upside+40.01%
P/B
GDTC2.39
Industry5.15
Upside-53.60%